Branded

FDA's approval of Poteligeo injection provides treatment options for rare, and hard-to-treat types of non-Hodgkin lymphoma.

Leo Pharma's acquisition of Bayer's branded topical prescription treatments include drugs for acne, fungal skin infections and rosacea, as well a range of topical steroids.

Sun Pharm's Kapspargo Sprinkle pellets can be sprinkled over soft food for patients who have difficulty swallowing.

FDA gives nod to Shionogi’s Mulpleta (lusutrombopag) for adults with chronic liver disease who are expected to have medical or dental procedures.

Lenvima/Keytruda combination therapy gets FDA breakthrough therapy designation for endometrial carcinoma, following collaboration between Eisai and Merck.

Azedra is the first FDA-approved drug for treating adults and adolescents age 12 years old and older with rare adrenal tumors, according to Progenics Pharmaceuticals.

Developed in collaboration with Neurocrine Biosciences, Orilissa is the first and only oral gonadotropin-releasing hormone antagonist specifically developed for women with moderate to severe endometriosis pain, AbbVie said. 

The Food and Drug Administration has approved Agios Pharmaceuticals’ Tibsovo (ivosidenib) tablets for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) who have a specific genetic mutation.